Skip to main content
. 2022 Nov 23;13:1050609. doi: 10.3389/fphys.2022.1050609

TABLE 4.

Differences in characteristics between responders and non-responders for 24-h diastolic BP in each exercise modality.

Responders Non-responders Δ p-value
Aerobic exercise, n (%) 10 (53) 9 (47)
Anti-hypertensive medications, n (%)
 Diuretics 5 (63) 5 (50) 0.664
 Angiotensin converting enzyme inibitors 4 (50) 2 (20) 0.321
 Angiotensin receptor antagonists 0 (0) 1 (10) 1000
 Calcium channel blockers 0 (0) 3 (30) 0.216
 Angiotensin II receptor blockers 4 (50) 2 (20) 0.321
Systolic ABPM, mmHg
 24-hour Exercise 126 ± 6 (120 to 131) 127 ± 10 (118 to 136) −1 ± 12 (−11 to 7) 0.673
 24-hour Control 131 ± 10 (123 to 136) 125 ± 12 (115 to 138) 6 ± 15 (−4 to 17) 0.188
 Δ 24-hour −5 ± 4 (−9 to 2) 2 ± 5 (−4 to 4) −7 ± 6 (−12 to −2) 0.013
Diastolic ABPM, mmHg
 24-hour Exercise 74 ± 7 (70 to 79) 76 ± 8 (69 to 84) −2 ± 9 (−11 to 5) 0.421
 24-hour Control 78 ± 9 (71 to 82) 74 ± 8 (67 to 83) 4 ± 12 (−3 to 12) 0.219
 Δ 24-hour −4 ± 2 (−6 to −2) 2 ± 3 (−1 to 5) −6 ± 3 (−9 to −3) <0.001
Combined exercise, n (%) 5 (26) 14 (74)
Anti-hypertensive medications, n (%)
 Diuretics 3 (60) 3 (21) 0.262
 β blockers 1 (20) 4 (29) 0.709
 Angiotensin converting enzyme inibitors 1 (20) 4 (29) 0.709
 Angiotensin receptor antagonists 1 (20) 1 (7) 0.421
 Calcium channel blockers 1 (20) 6 (43) 0.603
Systolic ABPM, mmHg
 24-hour Exercise 121 ± 3 (117 to 126) 130 ± 10 (124 to 136) −9 ± 11 (−20 to 1) 0.076
 24-hour Control 123 ± 5 (115 to 131) 128 ± 11 (121 to 134) −5 ± 11 (−15 to 7) 0.470
 Δ 24-hour −2 ± 4 (−8 to 5) 2 ± 6 (-1 to 6) −4 ± 6 (−11 to 2) 0.191
Diastolic ABPM, mmHg
 24-hour Exercise 69 ± 4 (62 to 75) 79 ± 8 (74 to 84) −10 ± 8 (−20 to −1) 0.028
 24-hour Control 72 ± 4 (66 to 78) 77 ± 9 (72 to 83) −5 ± 8 (−14 to 5) 0.337
 Δ 24-hour −3 ± 2 (−6 to −1) 2 ± 3 (0 to 3) −5 ± 2 (−8 to −2) 0.005
Resistance exercise, n (%) 8 (35) 15 (65)
Anti-hypertensive medications, n (%)
 Diuretics 6 (75) 13 (87) 0.589
 β blockers 1 (13) 6 (40) 0.345
 Angiotensin converting enzyme inibitors 3 (38) 4 (27) 0.709
 Angiotensin receptor antagonists 5 (63) 9 (60) 0.907
 Calcium channel blockers 2 (25) 3 (20) 0.787
Systolic ABPM, mmHg
 24-hour Exercise 128 ± 11 (119 to 138) 132 ± 12 (125 to 139) −4 ± 14 (−15 to 7) 0.441
 24-hour Control 136 ± 14 (124 to 148) 128 ± 13 (121 to 135) 8 ± 16 (−4 to 20) 0.171
 Δ 24-hour −8 ± 6 (−13 to −3) 4 ± 4 (2 to 7) −12 ± 5 (−17 to −8) <0.001
Diastolic ABPM, mmHg
 24-hour Exercise 72 ± 8 (66 to 78) 78 ± 11 (72 to 84) −6 ± 11 (−15 to 3) 0.194
 24-hour Control 78 ± 9 (70 to 85) 76 ± 10 (70 to 82) 2 ± 14 (−8 to 10) 0.798
 Δ 24-hour −6 ± 4 (−9 to −2) 2 ± 2 (0 to 3) −8 ± 2 (−10 to −5) <0.001
Isometric handgrip exercise, n (%) 8 (44) 10 (56)
Anti-hypertensive medications, n (%)
 Diuretics 5 (63) 5 (50) 0.664
 Angiotensin converting enzyme inhibitors 4 (50) 2 (20) 0.321
 Angiotensin receptor antagonists 0 (0) 1 (10) 1.000
 Calcium channel blockers 0 (0) 3 (30) 0.216
Systolic ABPM, mmHg
 24-hour Exercise 134 ± 13 (123 to 145) 137 ± 12 (129 to 145) −3 ± 19 (−18 to 10) 0.531
 24-hour Control 133 ± 14 (121 to 145) 137 ± 14 (128 to 147) −4 ± 16 (−15 to 10) 0.652
 Δ 24-hour 1 ± 7 (−6 to 5) 0 ± 8 (−6 to 6) 1 ± 11 (−9 to 6) 0.741
Diastolic ABPM, mmHg
 24-hour Exercise 79 ± 4 (76 to 82) 83 ± 8 (77 to 88) −4 ± 8 (−11 to 3) 0.217
 24-hour Control 82 ± 4 (79 to 86) 81 ± 8 (75 to 87) 1 ± 8 (−6 to 8) 0.709
 Δ 24-hour −3 ± 2 (−5 to −2) 2 ± 2 (0 to 3) −5 ± 2 (−7 to −3) <0.001

Values are Means ± standard deviation (95% Confidence Interval); BMI, body mass index; ABPM, ambulatory blood pressure monitoring; Δ ABPM is comparing the results of the interventions (exercise session minus control session).

Bold p-values indicate significant results (p < 0.05).